Literature DB >> 33462013

New onset adrenal insufficiency in a patient with COVID-19.

Maram Hashim1, Syed Athar1, Waqar Haider Gaba2.   

Abstract

SARS-CoV-2 is the cause of COVID-19. Since the outbreak and rapid spread of COVID-19, it has been apparent that the disease is having multi-organ system involvement. Still its effect in the endocrine system is not fully clear and data on cortisol dynamics in patients with COVID-19 are not yet available. SARS-CoV-2 can knock down the host's cortisol stress response. Here we present a case of a 51-year-old man vomiting for 10 days after having confirmed COVID-19 infection. He had hypotension and significant hyponatraemia. Work-up was done including adrenocorticotropic hormone stimulation test. He was diagnosed as suffering from adrenal insufficiency and started on steroids with subsequent improvement in both blood pressure and sodium level. COVID-19 can cause adrenal insufficiency. Clinicians must be vigilant about the possibility of an underlying relative cortisol deficiency in patients with COVID-19. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  adrenal disorders; fluid electrolyte and acid-base disturbances

Year:  2021        PMID: 33462013     DOI: 10.1136/bcr-2020-237690

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

Review 1.  Potential of Endogenous Oxytocin in Endocrine Treatment and Prevention of COVID-19.

Authors:  Stephani C Wang; Fengmin Zhang; Hui Zhu; Haipeng Yang; Yang Liu; Ping Wang; Vladimir Parpura; Yu-Feng Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-03       Impact factor: 6.055

2.  VZV Infection of Primary Human Adrenal Cortical Cells Produces a Proinflammatory Environment without Cell Death.

Authors:  Christy S Niemeyer; Teresa Mescher; Andrew N Bubak; Eva M Medina; James E Hassell; Maria A Nagel
Journal:  Viruses       Date:  2022-03-25       Impact factor: 5.818

3.  Fatal case of disseminated cryptococcal infection and meningoencephalitis in the setting of prolonged glucocorticoid use in a Covid-19 positive patient.

Authors:  Krupa Karnik; Yuexiu Wu; Samantha Ruddy; Bladimir Quijano-Rondan; Carl Urban; Glenn Turett; Lok Yung; Nishant Prasad; James Yoon; Sorana Segal-Maurer
Journal:  IDCases       Date:  2022-01-06

4.  SARS-CoV-2 Psychiatric Sequelae: A Review of Neuroendocrine Mechanisms and Therapeutic Strategies.

Authors:  Mary G Hornick; Margaret E Olson; Arun L Jadhav
Journal:  Int J Neuropsychopharmacol       Date:  2022-01-12       Impact factor: 5.176

5.  Primary Adrenal Insufficiency After COVID-19 Infection.

Authors:  Julienne Sánchez; Melissa Cohen; Joseph L Zapater; Yuval Eisenberg
Journal:  AACE Clin Case Rep       Date:  2021-11-14

6.  Impact of COVID-19 on the Endocrine System: A Mini-review.

Authors:  Sophie A Clarke; Ali Abbara; Waljit S Dhillo
Journal:  Endocrinology       Date:  2022-01-01       Impact factor: 4.736

Review 7.  Adrenal Insufficiency in Coronavirus Disease 2019 (COVID-19)-Infected Patients without Preexisting Adrenal Diseases: A Systematic Literature Review.

Authors:  Mehrbod Vakhshoori; Maryam Heidarpour; Niloofar Bondariyan; Niyousha Sadeghpour; Zohreh Mousavi
Journal:  Int J Endocrinol       Date:  2021-09-14       Impact factor: 3.257

8.  Adrenal insufficiency as a post-COVID-19 sequela.

Authors:  Manisha D Katikar
Journal:  Indian J Anaesth       Date:  2021-12-22

Review 9.  COVID-19 and the Endocrine System: A Review of the Current Information and Misinformation.

Authors:  Samir Ahmed Mirza; Abdul Ahad Ehsan Sheikh; Michaela Barbera; Zainab Ijaz; Muhammad Ali Javaid; Rahul Shekhar; Suman Pal; Abu Baker Sheikh
Journal:  Infect Dis Rep       Date:  2022-03-11

Review 10.  Eosinophils and COVID-19: diagnosis, prognosis, and vaccination strategies.

Authors:  Helene F Rosenberg; Paul S Foster
Journal:  Semin Immunopathol       Date:  2021-03-16       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.